🇺🇸 FDA
Patent

US 10220117

Methods of mammalian retinal stem cell production and applications

granted A61KA61K35/30A61K35/545

Quick answer

US patent 10220117 (Methods of mammalian retinal stem cell production and applications) held by The Regents of the University of California expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K35/30, A61K35/545, A61K9/0046, A61P